Hal Barron serves as Executive at GENENTECH INC, where they oversee executive responsibilities. Since joining the company, Hal Barron has executed 14 insider transactions totaling $2.4M, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 5, 2018 involved transacting 100,000 shares valued at $8.7M.
Hal Barron currently holds 3,780 shares of GENENTECH INC (DNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hal Barron has been a net buyer of DNA stock. They have purchased $2.4M and sold $0 worth of shares.
Hal Barron's most recent insider trade was on Mar 5, 2018, when they sold 100,000 shares at $87.00 per share.
Get notified when new Form 4 filings are submitted
| $87.00 |
| Discretionary |
| Jan 5, 2018 | JUNO | $0 | Award | 336 | $N/A | Discretionary |
| Oct 5, 2017 | JUNO | $0 | Award | 361 | $N/A | Discretionary |
| Jul 5, 2017 | JUNO | $0 | Award | 516 | $N/A | Discretionary |
| Apr 5, 2017 | JUNO | $0 | Award | 698 | $N/A | Discretionary |
| Jan 5, 2017 | JUNO | $0 | Award | 768 | $N/A | Discretionary |
| Oct 5, 2016 | JUNO | $0 | Award | 438 | $N/A | Discretionary |
| Jul 5, 2016 | JUNO | $0 | Award | 328 | $N/A | Discretionary |
| Apr 5, 2016 | JUNO | $0 | Award | 335 | $N/A | Discretionary |
| Dec 23, 2014 | JUNO | $2.4M | Purchase | 100,000 | $24.00 | Discretionary |
| Jan 26, 2010 | ALXA | $0 | Award | 18,908 | $N/A | Discretionary |
| Mar 26, 2009 | DNA | $165.3K | Disposition | 1,740 | $95.00 | Discretionary |
| Jan 22, 2009 | ALXA | $0 | Award | 16,014 | $N/A | Discretionary |